Results 301 to 310 of about 7,587,845 (361)

Recombinant Therapeutic Protein Vaccines

Protein & Peptide Letters, 2013
Recombinant technology has ushered in a new era for the pharmaceutical industry. Protein therapeutics, including plasma-derived products and antibodies obtained from the serum of infected patients, have been successfully adopted and utilized to treat various indications.
Satoshi, Ohtake, Tsutomu, Arakawa
openaire   +2 more sources

Overproduction of recombinant proteins in plants

Plant Science, 2012
Recombinant protein production in microbial hosts and animal cell cultures has revolutionized the pharmaceutical and industrial enzyme industries. Plants as alternative hosts for the production of recombinant proteins are being actively pursued, taking advantage of their unique characteristics.
Erin, Egelkrout, Vidya, Rajan, John A, Howard   +2 more
openaire   +2 more sources

Preparation of Recombinant Proteins in Milk

2004
Using transgenic animals as the source of recombinant proteins has several specific advantages. Large amounts of proteins can be obtained, essentially from milk. These proteins are often properly processed. They are in a number of cases correctly folded, assembled, cleaved, glycosylated, gamma-carboxylated, and so on.
openaire   +3 more sources

[Recombinant protein folding and production].

Medecine sciences : M/S, 2005
The biotechnology of recombinant protein production is now entering its most advanced stage, and the growth of industrial protein pharmaceuticals provides solid proof of this evolution. However, the systematic conversion of genetic information into a biologically active protein is constantly confronted by the fundamental problem of protein folding in ...
Betton, Jean-Michel, Chaffotte, Alain
openaire   +2 more sources

Capillary electrophoresis of recombinant proteins

Journal of Chromatography B: Biomedical Sciences and Applications, 1997
Many naturally occurring proteins which are used therapeutically have been cloned and expressed in large quantities in bacterial, yeast or mammalian systems. Purification of these proteins by column chromatography generates high purity products with low levels of host protein contaminants.
K A, Denton, S A, Tate
openaire   +2 more sources

SCHEMA-Guided Protein Recombination

2004
Publisher Summary This chapter examines the different aspects of SCHEMA-guided protein recombination. SCHEMA is a scoring function that predicts which elements in homologous proteins can be swapped without disturbing the integrity of the structure. Using the structural coordinates of the parent proteins, SCHEMA identifies pairs of residues that are ...
Silberg, Jonathan J., Endelman, Jeffrey B., Arnold, Frances H.   +2 more
openaire   +3 more sources

Recombinant Proteins in Vaccine Development

2003
The outer membrane of Neisseria meningitidis contains a variety of proteins with the potential for inclusion in new meningococcal vaccines (1). Studies on the vaccine potential of these proteins would be facilitated by the production of pure recombinant protein, free from other components of the Neisseria outer membrane.
M, Christodoulides, K A, Jolley, J E, Heckels   +2 more
openaire   +2 more sources

Escherichia coli as a versatile cell factory: Advances and challenges in recombinant protein production.

Protein Expression and Purification
E. coli plays a substantial role in recombinant protein production. Its importance increased with the discovery of recombinant DNA technology and the subsequent production of the first recombinant insulin in E. coli. E.
İbrahim İncir, Özlem Kaplan
semanticscholar   +1 more source

Preparation of recombinant neuritin protein

Protein Expression and Purification
Neuritin plays an important role in promoting nerve injury repair and maintaining synaptic plasticity, making it a potential therapeutic target for the treatment of nerve injury and neurodegenerative diseases. The present study aimed to obtain an active, unlabeled neuritin protein.
Pingping, Meng, Liyan, Zhu, Jiatong, Guo, Yuanyuan, Li, Yu, Wei, Jiawei, Sun, Jingling, Zhu   +6 more
openaire   +2 more sources

Recombinant protein production and streptomycetes

Journal of Biotechnology, 2012
The biopharmaceutical market has come a long way since 1982, when the first biopharmaceutical product, recombinant human insulin, was launched. Just over 200 biopharma products have already gained approval. The global market for biopharmaceuticals which is currently valued at over US$99 billion has been growing at an impressive compound annual growth ...
Jozef, Anné, Bárbara, Maldonado, Jan, Van Impe, Lieve, Van Mellaert, Kristel, Bernaerts   +4 more
openaire   +2 more sources